Insider Transactions in Q1 2024 at Cor Medix Inc. (CRMD)
Insider Transaction List (Q1 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 13
2024
|
Joseph Todisco Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
13,561
+3.7%
|
$40,683
$3.74 P/Share
|
|
Jan 12
2024
|
Erin Mistry EVP, Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,389
-7.99%
|
$13,167
$3.47 P/Share
|
|
Jan 12
2024
|
Erin Mistry EVP, Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
50,000
+47.66%
|
-
|
|
Jan 12
2024
|
Matthew T David Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
5,216
-9.81%
|
$15,648
$3.47 P/Share
|
|
Jan 12
2024
|
Matthew T David Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
50,000
+48.47%
|
-
|
|
Jan 12
2024
|
Elizabeth Masson Hurlburt EVP |
SELL
Payment of exercise price or tax liability
|
Direct |
4,603
-7.94%
|
$13,809
$3.47 P/Share
|
|
Jan 12
2024
|
Elizabeth Masson Hurlburt EVP |
BUY
Grant, award, or other acquisition
|
Direct |
50,000
+46.3%
|
-
|
|
Jan 12
2024
|
Joseph Todisco Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
13,781
-3.9%
|
$41,343
$3.47 P/Share
|
|
Jan 12
2024
|
Joseph Todisco Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
133,333
+27.41%
|
-
|